July 28, 2017 5:08 AM ET


Company Overview of CytomX Therapeutics, Inc.

Executive Profile

Frederick W. Gluck

Co-Founder and Director, CytomX Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 9 different industries.

See Board Relationships


Mr. Frederick W. Gluck, also known as Fred, is the Co-Founder of both CytomX and Cynvenio Biosystems and serves as the Chairman of the Board at Cynenio Biosystems, Inc. Mr. Gluck has served as a Senior Counselor to McKinsey & Company, Inc. from July 1998 to July 2003 and from 1988 to 1994, he was the Managing Director at the firm. At McKinsey, Mr. Gluck consulted extensively with U.S., European and Far East companies, with particular emphasis in the telecommunications, ...

Corporate Headquarters

151 Oyster Point Boulevard
South San Francisco, California 94080

United States

Phone: 650-515-3185
Fax: 650-351-0353

Board Members Memberships

Co-Founder and Chairman
Co-Founder and Director


Unknown/Other Education
Columbia University
New York University
Master's Degree
New York University
Honorary Doctorate
Hofstra University
Bachelor's Degree
Manhattan College
Manhattan College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$47,500
Total Calculated Compensation$143,240

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CytomX Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.